Ingredient

Gemigliptin Tartrate Sesquihydrate

Zemiglitptin tartaric acid 1.5 hydrate is a blood glucose control ingredient used in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
8
Single ingredient
1
Combination
7
Prescription medication
8

MFDS ingredient code M254878

What does it do?

Zemiglitptin tartaric acid 1.5 hydrate is a diabetes treatment ingredient belonging to the DPP-4 inhibitor class. This ingredient is used to promote insulin secretion and inhibit blood sugar increases to lower blood glucose levels.

This ingredient inhibits the DPP-4 enzyme in the body, preventing the breakdown of incretin hormones. As a result, insulin secretion increases and blood sugar increases are inhibited, aiding in blood glucose control.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Zemiglitptin is more selective compared to other DPP-4 inhibitors, reducing the risk of side effects, and can maintain blood glucose control effects with once-daily dosing.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

8 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.